INNOVATIVE MEDTECH, INC. Quarterly Operating Income (Loss) in USD from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Innovative Medtech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2011 to Q3 2024.
  • Innovative Medtech, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$827K, a 463% decline year-over-year.
  • Innovative Medtech, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$4.95M, a 76.4% decline year-over-year.
  • Innovative Medtech, Inc. annual Operating Income (Loss) for 2024 was -$4.27M, a 17.9% decline from 2023.
  • Innovative Medtech, Inc. annual Operating Income (Loss) for 2023 was -$3.62M, a 80.2% increase from 2022.
  • Innovative Medtech, Inc. annual Operating Income (Loss) for 2022 was -$18.3M, a 2476% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$4.95M -$827K -$680K -463% Jul 1, 2024 Sep 30, 2024 10-Q/A 2024-11-20
Q2 2024 -$4.27M -$3.07M -$2.26M -280% Apr 1, 2024 Jun 30, 2024 10-K 2024-10-16
Q1 2024 -$2.01M -$902K +$20.1K +2.18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 -$2.03M -$157K +$776K +83.2% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-16
Q3 2023 -$2.81M -$147K +$816K +84.8% Jul 1, 2023 Sep 30, 2023 10-Q/A 2024-11-20
Q2 2023 -$3.62M -$807K +$16.8M +95.4% Apr 1, 2023 Jun 30, 2023 10-K 2024-10-16
Q1 2023 -$20.4M -$922K -$728K -375% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 -$19.7M -$932K -$787K -539% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-16
Q3 2022 -$18.9M -$963K -$665K -223% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$18.3M -$17.6M -$17.4M -9046% Apr 1, 2022 Jun 30, 2022 10-K 2023-10-13
Q1 2022 -$831K -$194K +$212K +52.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$1.04M -$146K -$69.2K -90.3% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-21
Q3 2021 -$974K -$298K -$265K -796% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$709K -$193K Apr 1, 2021 Jun 30, 2021 10-K 2022-10-13
Q1 2021 -$406K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$76.7K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-22
Q3 2020 -$33.3K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q1 2014 -$284K -$58.7K +$131 +0.22% Feb 1, 2014 Apr 30, 2014 10-Q 2021-02-01
Q4 2013 -$285K -$109K -$342 -0.32% Nov 1, 2013 Jan 31, 2014 10-Q 2021-02-01
Q3 2013 -$284K -$58.3K +$525K +90% Aug 1, 2013 Oct 31, 2013 10-K 2021-02-01
Q2 2013 -$809K -$58.8K +$71.3K +54.8% May 1, 2013 Jul 31, 2013 10-Q 2021-02-01
Q1 2013 -$880K -$58.8K +$294K +83.3% Feb 1, 2013 Apr 30, 2013 10-Q 2021-02-01
Q4 2012 -$1.17M -$108K +$246K +69.4% Nov 1, 2012 Jan 31, 2013 10-Q 2021-02-01
Q3 2012 -$1.42M -$583K Aug 1, 2012 Oct 31, 2012 10-K 2021-02-01
Q2 2012 -$130K May 1, 2012 Jul 31, 2012 10-Q 2021-02-01
Q1 2012 -$353K Feb 1, 2012 Apr 30, 2012 10-Q 2021-02-01
Q4 2011 -$354K Nov 1, 2011 Jan 31, 2012 10-Q 2021-02-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.